Cargando…
The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
BACKGROUND: Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson’s disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223566/ https://www.ncbi.nlm.nih.gov/pubmed/28069007 http://dx.doi.org/10.1186/s12906-016-1525-y |